The Activation of PI3K/AKT/mTOR Signaling Pathway in Response to Cabazitaxel Treatment in Metastatic Castration-Resistant Prostate Cancer Cells

Objective: Despite advances in treatment approaches, metastatic castration-resistant prostate cancer (mCRPC) remains a clinical challenge to treat. Cabazitaxel (Cab), a third-line chemotherapy option for mCRPC, exhibits limited efficiency due to the activation of different signaling pathways associa...

Full description

Saved in:
Bibliographic Details
Main Authors: Işıl Ezgi Eryılmaz, Gamze Güney Eskiler, Ceyda Çolakoğlu, Ünal Egeli, Gülşah Çeçener
Format: Article
Language:English
Published: Istanbul University Press 2021-12-01
Series:European Journal of Biology
Subjects:
Online Access:https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/48FC9FBB32144584A2EE4DEEEC7A2736
Tags: Add Tag
No Tags, Be the first to tag this record!